SEL-rhBDNF

N/A

Report date: 2024/09/26 10:25:04

Base Information

Drug NameSEL-rhBDNF
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOptic Nerve DiseasesGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesManzanita Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesManzanita Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOptic Nerve DiseasesGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A